卡弗儲蓄 CARV 深 滬
等待開盤 11-26 09:30:00 美东时间
1.55
-0.030
-1.90%
華盛通- 最 高1.669
- 今 開1.59
- 成交量 4.79万股
- 最 低 1.53
- 昨 收 1.58
- 總市值 786.87万
- 52周最高 3.85
- 市盈率 靜 --
- 換手率 0.94%
- 52周最低 1.30
- 委 比 99.41%
- 總股本 507.66万
- 歷史最高 42.50
- 量 比 0.28
- 振 幅 8.80%
- 歷史最低 1.10
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Carver Bancorp To Deregister Its Common Stock With The SEC And Delist Its Common Stock From The Nasdaq To The OTCQX Market; Last Trading Day On Nasdaq To Be On Or About December 5, 2025
Carver Bancorp, Inc. (the "Company") (NASDAQ:CARV), the holding company for Carver Federal Savings Bank, today announced its voluntary decision to deregister its common stock with the Securities and Exchange Commission
11-19 06:03
Carver Bancorp Q2 EPS $(0.46) Down From $(0.41) YoY, Sales $6.381M Down From $6.579M YoY
Carver Bancorp (NASDAQ:CARV) reported quarterly losses of $(0.46) per share. This is a 12.2 percent decrease over losses of $(0.41) per share from the same period last year. The company reported $6.381 million in sales
11-14 06:12
Carver Bancorp, Inc. Announces Board Modernization Initiative with Comprehensive Governance Enhancements
Governance changes are designed to align Carver's board policies with leading companies, reinforcing the board's fiduciary commitment to all shareholders. The modernization plan includes a 7...
11-05 21:30
金斯瑞生物科技盘初涨超3% CARVYKTI®第三季度产生贸易销售净额约5.24亿美元
金斯瑞生物科技（01548）盘初涨超3%，截至发稿，股价上涨1.63%，现报16.18港元，成交额3583.05万港元。 10月14日，金斯瑞生物科技发布公...
10-15 09:44
金斯瑞生物科技：CARVYKTI®于截至2025年9月30日止季度产生贸易销售净额约5.24亿美元
金斯瑞生物科技（01548）公布，根据传奇与Janssen Biotech， Inc．（杨森）于2017年12月21日订立的合作及许可协议，CARVYKTI®于...
10-15 08:37
FDA Approves Labeling Changes Including Boxed Warning For Immune Effector Cell-Associated Enterocolitis After Treatment With Ciltacabtagene Autoleucel; Determined Overall Benefit Of CARVYKTI Continues To Outweigh Potential Risks For Approved Use
https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-labeling-changes-include-boxed-warning-immune-effector-cell-associated-enterocolitis
10-11 05:32
近两个月股价最大跌幅达25%，二次上市会是传奇生物(LEGN.US)股价反弹良方？
今年9月5日，彭博社援引知情人士消息称，由于投资者对制药商表现出浓厚兴趣，传奇生物(LEGN.US)正考虑在美国以外进行二次上市。根据外媒报道，传奇生物已经与潜在顾问讨论了上市方案，上市地点或是香港、新加坡或伦敦。
09-21 20:14
5 Financial Stocks Struggle With Expansion, Lagging Behind Sector Peers
The latest Benzinga Edge growth rankings reveal that several financial sector s...
08-24 23:01
金斯瑞生物科技：营收大增81.9%，经调净利增速超5倍，盈利韧性穿越周期
复杂多变的全球环境，往往孕育新机遇。 国产创新药成功出海案例频现，顶层政策支持持续加码（如丙类目录推出），正有力拉动创新药产业链需求。资本市场方面，港股创新药板...
08-20 14:27
